M&A Deal Summary

BICO Acquires QInstruments

On October 1, 2021, BICO acquired medical products company QInstruments for 61M EUR

Acquisition Highlights
  • This is BICO’s 1st transaction in the Medical Products sector.
  • This is BICO’s largest (disclosed) transaction.
  • This is BICO’s 1st transaction in Germany.

M&A Deal Summary

Date 2021-10-01
Target QInstruments
Sector Medical Products
Buyer(s) BICO
Deal Type Add-on Acquisition
Deal Value 61M EUR

Target

QInstruments

Jena, Germany
QInstruments is a developer, manufacturer, and supplier of advanced sample preparation automation by mixing solutions for liquid handling robots and workflows for biomedical and life science research and clinical diagnostics. QInstruments was founded in 2003 and is based in Jena, Germany.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

BICO

Gothenburg, Sweden

Category Company
Founded 2016
Sector Life Science
Employees832
Revenue 2.3B SEK (2023)
DESCRIPTION

BICO is a bio convergence company that combines different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology. With a focus on the application areas of bioprinting, multi-omics, cell line development, and diagnostics, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. BICO was founded in 2016 and is based in Gothenburg, Sweden.


DEAL STATS #
Overall 3 of 3
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 3 of 3
Country (Germany) 1 of 1
Year (2021) 3 of 3
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-15 Hurel

North Brunswick Township, New Jersey, United States

Hurel uses cell biology and microfluidics in a “chip” to help drug companies predict pre-clinically the drug candidates with the best chances of winning FDA approval. Hurel was founded in 2005 and is based in North Brunswick Township, New jersey.

Buy -